Treatment of hepatitis C with daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy in patients who are treatment naive or have previously failed an interferon based therapy.

被引：0
|
作者：
Lawitz, EJ [1 ]
Kadakia, SC [1 ]
Cantu, N [1 ]
Nader, P [1 ]
Cox, J [1 ]
Ganeshappa, KP [1 ]
Reddy, G [1 ]
Nguyen, TT [1 ]
Diamond, K [1 ]
Lindner, M [1 ]
Ostower, V [1 ]
Vemura, R [1 ]
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)81746-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6625
引用
收藏
页码：A1462 / A1462
页数：1
相关论文
共 50 条
  • [31] Response to interferon alpha 2B plus ribavirin in hepatitis C infected patients who failed interferon alpha 2B monotherapy.
    King, JW
    Favrot, DR
    Shakhashiro, A
    Gholson, CF
    Balart, LA
    Achord, J
    Kirkikis, JA
    Lyles, WE
    Hollier, JD
    Srinivas, D
    HEPATOLOGY, 1998, 28 (04) : 708A - 708A
  • [32] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [33] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [34] Induction interferon α2b 5MU daily for 4 weeks followed by combination interferon-ribavirin venus interferon-ribavirin without induction for previously untreated chronic hepatitis C
    Lebovics, E
    Castillo, E
    Rampersaud, P
    Hirsch, J
    Casellas, A
    McFarlane, C
    Esposito, S
    Tobias, H
    Geders, J
    Jacobson, I
    Klion, F
    Wolf, DC
    GASTROENTEROLOGY, 2001, 120 (05) : A570 - A571
  • [35] An open label trial of daily interferon induction followed by combination of ribavirin and rich daily dose interferon therapy for HCV infection.
    Li, J
    Ricci, P
    Cubbedge, L
    Bruno, CJ
    Lambiase, LR
    GASTROENTEROLOGY, 2000, 118 (04) : A1464 - A1464
  • [36] Interferon plus ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus
    Iino, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 216 - 217
  • [37] High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 113 - 114
  • [38] Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C
    Juszczyk, J
    Bolewska, B
    Cianciara, J
    Jablonska, J
    Zaborowski, P
    Niedzialek, D
    Gladysz, A
    Piszko, P
    JOURNAL OF HEPATOLOGY, 2000, 32 : 199 - 199
  • [39] Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
    Shiffman, ML
    Hofmann, CM
    Gabbay, J
    Luketic, VA
    Sterling, RK
    Sanyal, AJ
    Contos, MJ
    Ryan, MJ
    Yoshida, C
    Rustgi, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) : 2928 - 2935
  • [40] Efficacy of daily interferon-alpha in combination with ribavirin in the treatment of naive patients MQTH chronic hepatitis C.
    Urbanek, P
    HEPATOLOGY, 2002, 36 (04) : 578A - 578A
12345